Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H10N4OS |
| Molecular Weight | 234.278 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)\C(=N\NC(N)=S)C2=CC=CC=C12
InChI
InChIKey=DLGSOJOOYHWROO-XYOKQWHBSA-N
InChI=1S/C10H10N4OS/c1-14-7-5-3-2-4-6(7)8(9(14)15)12-13-10(11)16/h2-5H,1H3,(H3,11,13,16)/b12-8+
| Molecular Formula | C10H10N4OS |
| Molecular Weight | 234.278 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. | 2003-01 |
|
| Cidofovir in the treatment of poxvirus infections. | 2002-07 |
|
| Inhibition of human immunodeficiency virus by N-methylisatin-beta 4':4'-diethylthiosemicarbazone and N-allylisatin-beta-4':4'-diallythiosemicarbazone. | 1994-08 |
|
| Inactivation of herpes simplex virus by thiosemicarbazones and certain cations. | 1974-04 |
|
| Antiviral agents. 5H-as-Triazino(5,6-b) indoles. | 1972-03 |
|
| Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice. | 1968 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14171075
The present recommendations are that adults should receive 6 g. methisazone (four capsules of Marboran) a day, taken 3 g. in the morning and 3 g. in the evening. Dosage is halved for children between 3 and 10 and proportionately reduced still
further for infants.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:49:00 GMT 2025
by
admin
on
Mon Mar 31 17:49:00 GMT 2025
|
| Record UNII |
K3QML4J07E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QJ05AA01
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
||
|
WHO-ATC |
J05AA01
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5357051
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
METISAZONE
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
DB13641
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
217-616-2
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
70969
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
DTXSID7046413
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
1742
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
1910-68-5
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
CHEMBL362994
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
C77928
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
K3QML4J07E
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
m7319
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | Merck Index | ||
|
69811
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
SUB08895MIG
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
1746
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY | |||
|
100000080935
Created by
admin on Mon Mar 31 17:49:00 GMT 2025 , Edited by admin on Mon Mar 31 17:49:00 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |